Piklu Mallick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Piklu Mallick has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Laura Müller
Max-Planck-Institute for Dynamics and Self-Organization
3 shared publications - Sebastian Contreras
Max Planck Institute for Dynamics and Self-Organization
3 shared publications - Philipp Dönges
Max Planck Institute for Dynamics and Self-Organization
2 shared publications - Viola Priesemann
Max Planck Institute for Dynamics and Self-Organization, 37077 Göttingen, Germany
2 shared publications - Andreas Reitenbach
Sociology and Computational Social Science, Karlsruhe Institute of Technology, Douglasstraße 24, Karlsruhe, Baden-Württemberg, 76131, GERMANY
1 shared publication - André Calero Valdez
University of Lübeck
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Elsevier in Chaos, Solitons & Fractals
- Vol. 210
Stability and bifurcations of a minimal model for the effect of PrEP-related risk compensation in epidemics of sexually transmitted infections
- 19 June 2026
- Published by Elsevier in Chaos, Solitons & Fractals
- Vol. 210
Open AccessStability and bifurcations of a minimal model for the effect of PrEP-related risk compensation in epidemics of sexually transmitted infections
- Open Access
- 29 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (44)
Testing paradox may explain increased observed prevalence of bacterial STIs among MSM on HIV PrEP: A modeling study
HIV pre-exposure prophylaxis (PrEP) is transforming global HIV prevention, but its implementation coincides with observations of rising bacterial sexually transmitted infection (STI) rates among men who have sex with men, raising questions about whether PrEP is preventing one epidemic while facilitating others. To reconcile this apparent contradiction, we developed a minimal dynamical model of the simultaneous transmission of HIV and chlamydia (as an example of a curable STI). The model integrates three key mechanisms: 1) risk-mediated self-protective behavior, 2) reduction in condom use among PrEP users, and 3) PrEP-related asymptomatic STI screening. We show that these mechanisms can generate a “testing paradox:” True STI prevalence may decline while observed trends rise. This paradox emerges because increased PrEP uptake amplifies screening intensity, which can lower transmission but simultaneously inflate detection. By systematically mapping the parameter space of PrEP uptake, screening frequency, and risk perception, we identify broad and plausible conditions under which the paradox arises. Our findings reconcile conflicting epidemiological evidence and remark that the net effect of PrEP on STI dynamics depends critically on asymptomatic screening strategies. These results highlight the potential dual role of PrEP programs in reducing both HIV and bacterial STI incidence, while emphasizing the need to align screening and treatment policies to maximize benefits and minimize risks, e.g., antimicrobial resistance.
- 29 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (44)
Open AccessTesting paradox may explain increased observed prevalence of bacterial STIs among MSM on HIV PrEP: A modeling study
HIV pre-exposure prophylaxis (PrEP) is transforming global HIV prevention, but its implementation coincides with observations of rising bacterial sexually transmitted infection (STI) rates among men who have sex with men, raising questions about whether PrEP is preventing one epidemic while facilitating others. To reconcile this apparent contradiction, we developed a minimal dynamical model of the simultaneous transmission of HIV and chlamydia (as an example of a curable STI). The model integrates three key mechanisms: 1) risk-mediated self-protective behavior, 2) reduction in condom use among PrEP users, and 3) PrEP-related asymptomatic STI screening. We show that these mechanisms can generate a “testing paradox:” True STI prevalence may decline while observed trends rise. This paradox emerges because increased PrEP uptake amplifies screening intensity, which can lower transmission but simultaneously inflate detection. By systematically mapping the parameter space of PrEP uptake, screening frequency, and risk perception, we identify broad and plausible conditions under which the paradox arises. Our findings reconcile conflicting epidemiological evidence and remark that the net effect of PrEP on STI dynamics depends critically on asymptomatic screening strategies. These results highlight the potential dual role of PrEP programs in reducing both HIV and bacterial STI incidence, while emphasizing the need to align screening and treatment policies to maximize benefits and minimize risks, e.g., antimicrobial resistance.